NovoPen Echo, an Insulin Pen Designed with Children in Mind

NOVOPEN ECHO Insulin Pen Device
NOVOPEN ECHO Insulin Pen Device

Novo Nordisk announced that NovoPen Echo is now available. NovoPen Echo is the first insulin pen device available with half-unit dosing and a memory function that records the dose and elapsed time.

RELATED: Endocrine Disorders Resource Center

Half-unit dose increments allow for more detailed adjustments, which can be particularly important for the pediatric population. Other key features include an easy-to-use dial that will not select more units than left in the cartridge, an end-of-dose click, a short button travel to ease self-injections, and an easy to change Penfill cartridge.

NovoPen Echo will be available to patients for use with NovoLog (insulin aspart [rDNA origin] injection) PenFill cartridges. Also, different removable skins will be available for a kid-friendly customized look.

For more information call (800) 727-6500 or visit